Concepts (102)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Abortion, Induced | 9 | 2024 | 93 | 1.870 |
Why?
|
| Criminal Law | 1 | 2022 | 28 | 0.760 |
Why?
|
| Substance-Related Disorders | 1 | 2022 | 830 | 0.440 |
Why?
|
| Pregnancy | 9 | 2024 | 1772 | 0.370 |
Why?
|
| Breast Neoplasms | 1 | 2024 | 1723 | 0.370 |
Why?
|
| Copepoda | 3 | 2014 | 6 | 0.310 |
Why?
|
| Misoprostol | 4 | 2022 | 27 | 0.270 |
Why?
|
| Hawaii | 5 | 2024 | 2011 | 0.250 |
Why?
|
| Mifepristone | 2 | 2022 | 34 | 0.200 |
Why?
|
| Oxytocin | 1 | 2022 | 24 | 0.190 |
Why?
|
| Methamphetamine | 1 | 2024 | 166 | 0.190 |
Why?
|
| Fetal Research | 1 | 2022 | 4 | 0.190 |
Why?
|
| Fentanyl | 1 | 2022 | 16 | 0.190 |
Why?
|
| Abortion, Spontaneous | 1 | 2022 | 27 | 0.180 |
Why?
|
| Quarantine | 1 | 2021 | 7 | 0.180 |
Why?
|
| Analgesics | 1 | 2022 | 55 | 0.180 |
Why?
|
| Vulnerable Populations | 1 | 2022 | 166 | 0.170 |
Why?
|
| Humans | 14 | 2024 | 43102 | 0.170 |
Why?
|
| Risk Assessment | 1 | 2024 | 863 | 0.170 |
Why?
|
| Female | 11 | 2024 | 24698 | 0.150 |
Why?
|
| Abortifacient Agents | 1 | 2019 | 12 | 0.150 |
Why?
|
| Data Collection | 1 | 2019 | 210 | 0.150 |
Why?
|
| Pain | 1 | 2022 | 290 | 0.140 |
Why?
|
| Hemostatics | 1 | 2018 | 10 | 0.140 |
Why?
|
| Patient Satisfaction | 1 | 2019 | 165 | 0.140 |
Why?
|
| Public Health | 1 | 2022 | 424 | 0.140 |
Why?
|
| Blood Loss, Surgical | 1 | 2018 | 15 | 0.140 |
Why?
|
| Uterine Hemorrhage | 1 | 2018 | 14 | 0.140 |
Why?
|
| Pit and Fissure Sealants | 1 | 2017 | 2 | 0.140 |
Why?
|
| Risk Factors | 1 | 2024 | 3994 | 0.120 |
Why?
|
| Telemedicine | 1 | 2019 | 234 | 0.110 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2014 | 300 | 0.110 |
Why?
|
| Carbon Monoxide | 1 | 2014 | 47 | 0.100 |
Why?
|
| Octopamine | 1 | 2013 | 9 | 0.100 |
Why?
|
| Histamine | 1 | 2013 | 19 | 0.100 |
Why?
|
| Circadian Rhythm Signaling Peptides and Proteins | 1 | 2013 | 2 | 0.100 |
Why?
|
| Adult | 4 | 2023 | 13872 | 0.100 |
Why?
|
| Serotonin | 1 | 2013 | 123 | 0.100 |
Why?
|
| Hydrogen Sulfide | 1 | 2014 | 77 | 0.100 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2013 | 166 | 0.100 |
Why?
|
| Ibuprofen | 2 | 2022 | 34 | 0.090 |
Why?
|
| Dopamine | 1 | 2013 | 275 | 0.090 |
Why?
|
| Nitric Oxide | 1 | 2014 | 386 | 0.080 |
Why?
|
| Double-Blind Method | 2 | 2022 | 317 | 0.080 |
Why?
|
| United States | 4 | 2023 | 5205 | 0.080 |
Why?
|
| Qualitative Research | 2 | 2023 | 574 | 0.080 |
Why?
|
| Signal Transduction | 2 | 2014 | 2157 | 0.070 |
Why?
|
| Amino Acid Sequence | 3 | 2014 | 1180 | 0.060 |
Why?
|
| Molecular Sequence Data | 3 | 2014 | 1542 | 0.060 |
Why?
|
| Biosynthetic Pathways | 2 | 2014 | 14 | 0.050 |
Why?
|
| Expressed Sequence Tags | 2 | 2014 | 28 | 0.050 |
Why?
|
| Cause of Death | 1 | 2024 | 186 | 0.050 |
Why?
|
| Sequence Alignment | 2 | 2014 | 272 | 0.050 |
Why?
|
| Contraception | 1 | 2023 | 60 | 0.050 |
Why?
|
| Counseling | 1 | 2023 | 138 | 0.050 |
Why?
|
| Insurance, Health | 1 | 2023 | 145 | 0.050 |
Why?
|
| Fetal Tissue Transplantation | 1 | 2022 | 4 | 0.050 |
Why?
|
| Aborted Fetus | 1 | 2022 | 5 | 0.050 |
Why?
|
| Pelvic Pain | 1 | 2022 | 10 | 0.050 |
Why?
|
| Oxycodone | 1 | 2022 | 7 | 0.050 |
Why?
|
| Pregnancy Trimester, First | 1 | 2022 | 20 | 0.050 |
Why?
|
| Acetaminophen | 1 | 2022 | 30 | 0.050 |
Why?
|
| Young Adult | 2 | 2023 | 5080 | 0.040 |
Why?
|
| Adolescent | 2 | 2023 | 6081 | 0.040 |
Why?
|
| Analgesics, Opioid | 1 | 2022 | 252 | 0.040 |
Why?
|
| Self Administration | 1 | 2019 | 69 | 0.040 |
Why?
|
| Methylergonovine | 1 | 2018 | 3 | 0.040 |
Why?
|
| Vasopressins | 1 | 2018 | 12 | 0.040 |
Why?
|
| Abortifacient Agents, Nonsteroidal | 1 | 2018 | 10 | 0.030 |
Why?
|
| Oxytocics | 1 | 2018 | 8 | 0.030 |
Why?
|
| Family Planning Services | 1 | 2018 | 34 | 0.030 |
Why?
|
| Gynecology | 1 | 2018 | 35 | 0.030 |
Why?
|
| Obstetrics | 1 | 2018 | 43 | 0.030 |
Why?
|
| Gestational Age | 1 | 2018 | 200 | 0.030 |
Why?
|
| Health Care Costs | 1 | 2017 | 91 | 0.030 |
Why?
|
| Dental Caries | 1 | 2017 | 57 | 0.030 |
Why?
|
| Middle Aged | 2 | 2024 | 12222 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 1 | 2017 | 179 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2019 | 1063 | 0.030 |
Why?
|
| Time Factors | 1 | 2019 | 1857 | 0.030 |
Why?
|
| Cystathionine beta-Synthase | 1 | 2014 | 16 | 0.030 |
Why?
|
| Heme Oxygenase (Decyclizing) | 1 | 2014 | 31 | 0.030 |
Why?
|
| Diffusion | 1 | 2014 | 63 | 0.030 |
Why?
|
| Vertebrates | 1 | 2014 | 34 | 0.030 |
Why?
|
| Dopa Decarboxylase | 1 | 2013 | 4 | 0.030 |
Why?
|
| Histidine Decarboxylase | 1 | 2013 | 2 | 0.030 |
Why?
|
| Phenylalanine Hydroxylase | 1 | 2013 | 2 | 0.030 |
Why?
|
| Mixed Function Oxygenases | 1 | 2013 | 31 | 0.030 |
Why?
|
| Isoenzymes | 1 | 2014 | 168 | 0.030 |
Why?
|
| Nitric Oxide Synthase | 1 | 2014 | 135 | 0.030 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2013 | 92 | 0.020 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2013 | 267 | 0.020 |
Why?
|
| Sequence Analysis, Protein | 1 | 2013 | 52 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2014 | 423 | 0.020 |
Why?
|
| Base Sequence | 1 | 2014 | 983 | 0.020 |
Why?
|
| Animals | 3 | 2014 | 16992 | 0.020 |
Why?
|
| Drosophila melanogaster | 1 | 2013 | 193 | 0.020 |
Why?
|
| Aged | 1 | 2024 | 8214 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2013 | 408 | 0.020 |
Why?
|
| Proteomics | 1 | 2013 | 378 | 0.020 |
Why?
|
| Phylogeny | 1 | 2014 | 769 | 0.020 |
Why?
|
| Male | 1 | 2024 | 23409 | 0.010 |
Why?
|